Eyal Attar
2023
In 2023, Eyal Attar earned a total compensation of $1.4M as Chief Medical Officer at Vor Biopharma.
Compensation breakdown
Non-Equity Incentive Plan | $180,286 |
---|---|
Option Awards | $437,090 |
Salary | $474,000 |
Stock Awards | $302,475 |
Other | $6,269 |
Total | $1,400,120 |
Attar received $474K in salary, accounting for 34% of the total pay in 2023.
Attar also received $180.3K in non-equity incentive plan, $437.1K in option awards, $302.5K in stock awards and $6.3K in other compensation.
Rankings
In 2023, Eyal Attar's compensation ranked 811th out of 2,647 executives tracked by ExecPay. In other words, Attar earned more than 69.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 811 | 69th |
Manufacturing | 477 | 67th |
Chemicals And Allied Products | 327 | 60th |
Drugs | 318 | 59th |
Biological Products, Except Diagnostic Substances | 102 | 50th |
Attar's colleagues
We found two more compensation records of executives who worked with Eyal Attar at Vor Biopharma in 2023.